Illumina, Inc.
ILMN
株式のランク
#600
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis... Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
株価
$268.04
時価総額
$40.47B
変化（1日）
2.05%
変化（1年）
169.39%
国
US
取引 Illumina, Inc. (ILMN)
カテゴリー
Healthcare
Illumina, Inc.（ILMN）の発行済株式数
June 2026 時点の発行済株式数 151.00M
Illumina, Inc. の最新の財務報告および株価によると、現在の発行済株式数は 151.00M です。December 2024 の終わりには、同社は 159.00M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Illumina, Inc.（ILMN）の発行済株式数の履歴（2000 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 151.00M | -1.31% |
| 2025 | 153.00M | -3.77% |
| 2024 | 159.00M | 0.63% |
| 2023 | 158.00M | 5.33% |
| 2022 | 150.00M | 2.04% |
| 2021 | 147.00M | 0.00% |
| 2019 | 147.00M | 0.00% |
| 2018 | 147.00M | 0.68% |
| 2017 | 146.00M | -0.68% |
| 2016 | 147.00M | 1.38% |
| 2015 | 145.00M | 6.97% |
| 2014 | 135.55M | 8.38% |
| 2013 | 125.08M | 1.69% |
| 2012 | 123.00M | -0.32% |
| 2011 | 123.40M | -0.15% |
| 2010 | 123.58M | 0.35% |
| 2009 | 123.15M | 5.39% |
| 2008 | 116.86M | 7.89% |
| 2007 | 108.31M | 21.69% |
| 2006 | 89.00M | 10.85% |
| 2005 | 80.29M | 12.00% |
| 2004 | 71.69M | 12.28% |
| 2003 | 63.85M | 3.35% |
| 2002 | 61.78M | 3.84% |
| 2001 | 59.50M | 6.95% |
| 2000 | 55.63M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 371.00M | 145.70% |
US
|
|
| 705.30M | 367.09% |
US
|
|
| 143.28M | -5.11% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 86.75% |
US
|
